Based on this, the expression of two HA receptors, CD44 (80 kDa) and RHAMM (85 kDa), was analyzed in the overexpressing cells as well as in the native BC cell lines using Western blot (Figure 6I). This evidence concerns the gene CD44 and breast cancer.